Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Movement Movement +8.01%
#3 COTI COTI +7.56%
#4 DMT-NAT DMT-NAT +7.27%
#5 Victoria VR Victoria VR +7.18%
#6 GRVT Token GRVT Token +4.67%
#7 Cryptopia Cryptopia +3.74%
#8 Kinetiq Kinetiq +3.53%
#9 Lisk Lisk +3.28%
#10 Jito Jito +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Clasificación en acciones #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Precio por acción
$0.85
Última sincronización: 2025-01-21
Capitalización bursátil
$411.40
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Fresh2 Group Limited (FRES)

Categoría

Healthcare
Ganancias de Fresh2 Group Limited (FRES)
Ganancias en Jun 2023 TTM: $-13.66M
Secondo gli ultimi rapporti finanziari di Fresh2 Group Limited, gli utili attuali della società sono $-13.66M. Nel 2021, la società ha registrato un utile di $-18.85M, una disminución en comparación con agli utili del 2020, che erano di $-11.67M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Fresh2 Group Limited desde 2017 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-13.66M -10.89%
2022 $-15.33M -18.70%
2021 $-18.85M 61.55%
2020 $-11.67M -20.14%
2019 $-14.61M 130.04%
2018 $-6.35M 7.85%
2017 $-5.89M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -38,721.23%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -14,382.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -22,106.96%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR